Back to News
Market Impact: 0.28

Prediction: Rocket Lab Stock Trades Above $100 Again Before 2029

Source: Nasdaq

Corporate Guidance & OutlookCompany FundamentalsTransportation & LogisticsM&A & RestructuringInvestor Sentiment & Positioning
Prediction: Rocket Lab Stock Trades Above $100 Again Before 2029

Rocket Lab's backlog reached a record $2.36 billion at midyear, up 137% year over year, while Q2 revenue rose 62% to $234 million and more than $1 billion of new contracts were signed in Q3. The article argues RKLB could return above $100 before 2029, implying roughly 35% upside and a near-$70 billion valuation, if revenue reaches about $3 billion by 2028 including the pending Iridium acquisition. Key execution risks are Neutron's delayed first launch timeline, expected mid-2027 Iridium closing, dilution from the deal and share issuance, and continued adjusted EBITDA losses projected at $17 million-$23 million next quarter.

Analysis

RKLB’s investment case has shifted from a launch-disruptor multiple to a capital-intensive integration-and-execution story. The pending IRDM acquisition can add recurring, higher-visibility service revenue and reduce reliance on milestone-driven space-systems contracts, but it also raises the required equity value creation: dilution and assumed transaction complexity mean revenue growth alone will not protect the multiple unless consolidated EBITDA margins improve. IRDM holders face a different setup: the stock consideration creates a de facto long-RKLB exposure through closing, so a widening deal spread would likely reflect financing, regulatory, or RKLB-share-price risk rather than deterioration in Iridium’s core cash generation.

The near-term catalyst is not backlog growth, which is already being capitalized, but evidence that conversion remains on schedule while cash burn is contained. Over the next 1-3 months, watch quarterly space-systems gross margin, operating-cash-flow burn, and new equity issuance; further capital raises would undermine the thesis that scale is producing self-funding economics. Over 6-18 months, Neutron schedule credibility is the pivotal variable: a pad milestone is materially less valuable than a successful flight, and repeat-flight cadence is required to challenge SpaceX’s cost and reliability advantage. Any material schedule slip could compress RKLB toward a defense/space-systems contractor valuation rather than sustain a platform premium.

Consensus appears too willing to treat contracted backlog as equivalent to high-quality recurring revenue. A substantial portion is likely exposed to customer milestones, procurement timing, and execution costs; rapidly growing backlog can worsen working capital and fixed-cost absorption before it improves free cash flow. Conversely, if IRDM closes without incremental dilution and its service cash flows fund Neutron development, the combined company could earn a lower cost of capital than standalone RKLB—an underappreciated strategic benefit, but one that cannot be verified until deal terms, financing, and post-close guidance are updated.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.18

Ticker Sentiment

IRDM0.25
RKLB0.38
SPCX-0.05

Key Decisions for Investors

  • Do not chase RKLB on a rebound toward $100 before next earnings. Require confirmation of stable/improving space-systems gross margin and no incremental equity raise; absent that, the risk/reward remains unfavorable because valuation leaves little room for a Neutron delay.
  • Establish a small IRDM merger-arbitrage watch position only after calculating the implied exchange value and annualized spread at announcement terms. Buy IRDM versus a hedge in RKLB only if the gross spread exceeds 12-15% annualized after borrow, hedge-ratio, and regulatory-close risk; exit on a financing amendment or material RKLB dilution.
  • For a 6-12 month tactical hedge against execution disappointment, consider a long IRDM/short RKLB relative-value position where deal mechanics permit. IRDM’s recurring service economics should be less sensitive to launch timing; thesis is falsified by a revised exchange ratio, a sharply narrowed deal spread, or Neutron milestones arriving ahead of plan.
  • Set alerts for Neutron schedule revisions, quarterly adjusted EBITDA/cash-burn guidance, and any equity-registration filing. A launch-date slip beyond 2027 or rising cash-burn guidance would be a catalyst to reduce RKLB exposure; a successful first flight alone is not sufficient—repeat-flight commitments and unit-economics disclosure are needed before upgrading.

More News

From AllMind Research

Browse all research